- Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and moreWelcome back to another edition of Endpoints Weekly! We’re doing a little bit of celebrating here at Endpoints, as we took home three Neal Awards, which recognize excellence in B2B journalism. The ...Endpoints · 2mo ago↗ source
- Sanofi MS drug rejected in US gets an endorsement in Europe<figure><div><img src="https://imgproxy.divecdn.com/FBR1IQNmU9Hqatva496Zg2G8JMHsqV0UGsf4LMARqYo/g:nowe:189:144/c:1776:1003/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS80OTY5MDc4Mzc…BioPharma Dive · 3mo ago↗ source
- Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus<figure><div><img src="https://imgproxy.divecdn.com/5gZG9o175Y-5hwnkjuD_z1dOVTvKeEM4IBu6BCXs-80/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9BYmJWaWVfRHVyaGFtX0NhbXB1cy5qcGc=.…